Delivery Order SPE2DB25D3108-SPE2DB25FPDMC
- Not listed
- The Defense Logistics Agency (DLA) awarded a $13,511.84 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric typhoid vaccine supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a delivery against...
- The Defense Logistics Agency awarded a $13,798 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract for a typhoid vaccine product. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $16,581.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, which must be completed by June 20, 2025, represents a small-value procurement from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $10,348.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with completion targeted for August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,724.75 to supply TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccination product. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,726.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vials (typhoid vaccine) with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $20,697.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price contract, with an ultimate completion date of September 9, 2025, represents a direct purchase of typhoid vaccine products to support federal medical procurement requirements. The award was made on a competitive basis with no set-aside designation, leveraging AmerisourceBergen's established capabilities as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract uses firm fixed price pricing and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,162.72 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a child delivery order under...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDMCDelivery Order
The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price, non-set-aside contract represents a pediatric typhoid vaccine product delivery to support federal medical supply needs. The award was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement and demonstrates significant capability in delivering vaccines and specialized pharmaceutical products to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The place of performance is located at the contractor's corporate office in Conshohocken, PA. This transaction exemplifies the company's role as a preferred supplier under the DLA's pharmaceutical distribution network, enabling rapid fulfillment of medical supply requirements across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/28/25 |